Knowledge Bank
Research Insight
Bayer Terminates Phase II Study with Riociguat in Patients with Pulmonary Hypertension Associated wi
Following the recommendation of an independent Data Monitoring Committee (DMC), Bayer is terminating its Phase II study investigating riociguat in patients with pulmonary hypertension associated...
Industry Reports
Fresenius Medical Care expects significant sales and earnings growth in 2016
Fresenius Medical Care, the world’s leading provider of dialysis products and services, expects significant sales and earnings growth in 2016. At the Annual General Meeting...
News
Royal Philips and UNFPA collaborate to transform lives in Mandera County, Kenya
The Community Life Center in Mandera is expected to provide the local area with modern, integrated high-quality health services, access to energy, education, employment opportunities,...
Research Insight
Edwards Lifesciences’ Philanthropy Impacts 200,000 Underserved Patients Through Every Heartbeat Matt
Edwards Lifesciences Corporation the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that reports from its philanthropic partners...
Industry Reports
Bayer Partners with BioNTech to Develop mRNA Vaccines, Drugs for Animal Health
Bayer and BioNTech AG, a leading immunotherapy company headquartered in Mainz, Germany have entered into an agreement to develop novel, first-in-class mRNA vaccines and therapeutics...
Industry Reports
Sonova Acquires AudioNova For EUR 830 million.
Sonova Holding AG, the world’s leading provider of hearing solutions, and AudioNova International B.V. one of Europe’s largest hearing aid retailers announced their intention to...
Industry Reports
St. Jude Medical Inc reports Second Quarter of Fiscal Year 2016
Board of directors declare second quarter dividend of $0.31 per shareHHM Global/Press releases/-St. Jude Medical, Inc. a global medical device company, today announced that its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.

















